Effects of Simvastatin Pretreatment on Clomiphene Response in Clomiphene - Resistant Women with Polycystic Ovary Syndrome
,
Abstract
Objective: The aim of this study is to determine if simvastatin pretreatment would change clomiphene response in clomiphene citrate-resistant (CC-R)women with (PCOS).
Materials and methods: This quasi experimental study included twenty five clomiphene resistant women with PCOS. All patients received cyclic oral contraceptives pills (OCP) (30µg of ethinyl estradiol and 150µg of desogestrol) from the 5th day of their spontaneous or progesterone (P) induced menstrual cycle; in addition, they received simvastatin (20mg/day) from the first day of cycle for two consecutive months. Then, patients were given 100 mg clomiphene citrate (CC) (Iran Hormone, Iran) for five days starting from day three of their menstrual cycles. The primary outcome measures were ovulation and pregnancy rates. The change in body mass index (BMI), the mean number of follicles ≥ 18 mm, the mean of follicular size and endometrial thickness on the day of human chorionic gonadotropin (HCG) administration were secondary outcome measures.
Results: Ovulation occurred in 5 out of 25 (20%) patients, but none of the patients conceived in this study. No important change in BMI was observed after using simvastatin (0.28 + 1.13; p = 0.228). In all patients with ovulation, the number of follicles ≥ 18mm was one. The mean follicular size and endometrial thickness on the day of HCG administration were 19.67 ± 2.04 and 7.00 ± 1.34, respectively.
Conclusion: In this study, we did not observe the favorable effect on ovulation and pregnancy rates with CC following of simvastatin pretreatment in CC-resistant PCOS women. So, further studies with a larger number of patients, higher doses of CC and more cycles are necessary to make this obvious.
Gardner DK,Weissman A,Howles CM,Shoham Z. Assisted Reproductive Technologies.3rd ed.United Kingdom:Informe health care;2009;721.
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89:2745–9.
Lidor AL ,Goldenberg M ,Cohen SB, Seidman DS, Mashiach S, Rabinovici J. Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment. Fertil Steril 2000; 74:749-52.
Polson DW,Kiddy DS,Mason HD, Franks S.Induction ovulation with clomiphene citrate in women with polycystic ovary syndrome:the difference between responders and nonresponders.Fertil Sterli 1989; 51:30-4.
George SS, George K, Irwin C, Job V, Selvakumar R, Jeyaseelan V, Seshadri MS. Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial. Hum Reprod 2003; 18:299-304.
Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992; 75:577–83.
Murakawa H, Hasegawa I ,Kurabayashi T, Tanaka K. Polycystic ovary syndrome.Insuline resistance and ovulatory response to clomiphene citrate.J Reprod Med1999;44:23-7.
Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43:647-54 .
Mitwally M.F, Kuscu N.K,Yalcinkaya TM.High ovulatory rates with use of troglitazone in clomiphene –resistant women with poly cystic ovary syndrome. Hum Repro. 1999; 14:2700-3.
Goldstein JL, Brown MS. Regulation of the mevalonate pathway.Nature1990; 343:425–30.
Duleba AJ, Bonaszewska B, Spaezynski RZ,Powelczyk L. Simvastatin improve biochemical parameters in women with polycystic ovary syndrome:results of a prospective randomize trial. Fertil Steril 2006; 85:996–1001.
Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. J Clin Endocrinol Metab 2007; 92:456-61.
Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial. J Clin Endocrinol Metab 2009 Dec; 94:4938-45.
Kazerooni T, Shojaei-Baghini A, Dehbashi S, Asadi N, Ghaffarpasand F, Kazerooni Y. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study. Fertil Steril2010; 94:2208-13.
Sathyapalan T, Kilpatrick ES, Coady AM, Atkin SL. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. J Clin Endocrinol Metab2009; 94:103–8.
Sathyapalan T, Kilpatrick ES, Coady AM, Atkin SL.Atorvastatin pretreatment augments the effect ofmetformin in patients with polycystic ovary syndrome (PCOS). Clin Endocrinol2010; 72: 566–8.
Sathyapalan T,Smith KA, Coady AM, Kilpatrick ES, Atkin SL Atorvastatin therapy decreases androstenedione anddehydroepiandrosterone sulphate concentrations in patientswith polycystic ovary syndrome: randomized controlled study.Ann Clin Biochem2012; 49:80-5.
Navali N,Pourabolghasem S,Fouladi RF,Nikpour MA.Theraputic effects of biguanide vs.statin in poly cystic ovary syndrome:a randomized clinical trial.Pak J Biol Sci 2011;14:658-63.
KayaC, Cengiz SD, Berker B, Demirtas S, Cesur M, Erdogan G.Comparative effects of atorvastatin and simvastatin onthe plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study .Fertil Steril 2009; 92:635-42.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised2003consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome.The Rotterdam ESHREASRM-sponsored pcos consensus workshop group.Fertil steril 2004; 81:19-25.
Speroff L,Fritz MA.Induction ovulation In :Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphi: Lippincott,Williams and Wilkins;2005: 499-530.
Kaya C, Pabuccu R, Cengiz SD, Dunder I. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study. Exp Clin Endocrinol Diabetes 2010; 118:161–6.
Raja-Khan N, Kunselman AR, Hogeman CS, Stetter CM, Demers LM, Legro RS. Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized,placebo-controlled trial. Fertil Steril 2010; 95:1849–52.
Izquierdo D, Foyouzi N, Kwintkiewicz J, Duleba AJ. Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis. Fertil Steril 2004;82:1193–7.
Sokalska A, Piotrowski PC, Rzepczynska IJ, Cress A,Duleba AJ. Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability. J Clin Endocrinol Metab 2010; 95: 5390–4.
Rashidi B, Abediasl J, Tehraninejad E, Rahmanpour H, Sills ES. Simvastatin Effects on Androgens, Inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: Results from a prospective,randomized, placebo-controlled clinical trial.J Investig Med 2011;59:912-6.
Gao L,Zhao FL,Li SC. Statin is a Reasonable Treatment Option for Patients with Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials. Exp Clin Endocrinol Diabetes 2012; 120: 367–75.
Al-Omari WR, Sulaiman WR, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2004;85:289-91.
Mitwally MF, Casper RF.Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75:305-9.
Elnashar A, Fouad H, Eldosoky M, Abelgafar N. Letrozole induction of ovulation in clomiphene citrate resistant polycystic ovary syndrome: responders and non-responders. Fertil Steril 2006;85:511-3.
Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod 2006;21:1432-5.
Azargoon A ,Alavy Toussy J, Fakhr Darbanan F. Pregnancies following the use of sequential treatment of metformin and incremental doses of letrozole in clomiphen-resistant women with polycystic ovary syndrome. Iran J Reproduc Med 2012; 10:33-40.
Ashrafi M, Zafarani F, Baghestani AR.Effects of metformin on ovulation and pregnancy rate in women with clomiphene resistant poly cystic ovary syndrome. Int J Fertil Steril 2007;1: 39-42.
| Files | ||
| Issue | Vol 7, No 4 (December 2013) | |
| Section | Original Articles | |
| Keywords | ||
| Clomiphene-Resistant Poly Cystic Ovary Syndrome Simvastatin Statins | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
